News
In this episode presented by Eclipsebio, BioSpace's head of insights Lori Ellis discusses mRNA and srRNA with Andy Geall of ...
The U.S. Food and Drug Administration has granted full approval for Moderna's COVID-19 vaccine, Spikevax, in children aged 6 ...
Institutions like OMRF have had almost unbroken bipartisan support as a national biomedical research policy. Breaking it ...
Researchers from Tel Aviv University and the Israel Institute for Biological Research in Ness Ziona have used the platform ...
The elephant vaccine closely resembles other mRNA vaccines made for humans. mRNA packed in lipid nanoparticles carries ...
We came across a bullish thesis on Moderna, Inc. (MRNA) on Natan’s Substack. In this article, we will summarize the bulls’ thesis on MRNA. Moderna, Inc. (MRNA)’s share was trading at $26.67 as of 13th ...
Its pipeline is focused on the development of infectious respiratory disease vaccines.Arcturus is developing an avian flu vaccine based on its STARR self-amplifying mRNA vaccine platform technology.
Vaccine Approvals: Health Secretary Robert F. Kennedy Jr. announced plans to require all new vaccines to be tested against placebos and to develop new vaccines without using mRNA technology, moves ...
In RSV, CMV, norovirus, our combination vaccine, flu and many of those just ramped down and are completed by 2027. We had never really given guidance for 2027.
Norovirus vaccine: The two-season Phase 3 study evaluating the efficacy, safety and immunogenicity of Moderna's trivalent vaccine against norovirus (mRNA-1403) is fully enrolled in the Northern ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results